ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Perifosine Increases PFS In Phase II Study

December 30, 2011

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980

Marie Lombardi NCAB Member, Dies; HHS Holding Up Board Appointments

April 23, 1982

Funding opportunities listed.

September 17, 2004

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

July 25, 2014

1.7% Cut Expected in NCI Budget Under Deficit Agreement

November 24, 1989